KLF13 anticorps (AA 27-37)

N° du produit ABIN636181

Détail du produit anti-KLF13 anticorps

Antigène: KLF13 (Kruppel-Like Factor 13 (KLF13))

Épitope: AA 27-37

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp KLF13 est non-conjugé

Application: Western Blotting (WB)

Purification: Affinity chromatography purified

Immunogène: RFLAT1 antibody was raised in rabbit using AA 27-37 [PREGPESRPEG] of the Kruppel-like factor 13, transcription factor NSLP1, novel Sp1 like zinc finger transcription factor, and RANTES factor of late activated T lymphocytes-1 as the immunogen.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: Lot specific

Buffer: Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Détails sur KLF13

Antigène: KLF13 (Kruppel-Like Factor 13 (KLF13))

Autre désignation: RFLAT1 (KLF13 Produits)

Synonymes: anticorps KLF13, anticorps klf13l, anticorps zgc:152886, anticorps BTEB3, anticorps FKLF2, anticorps NSLP1, anticorps RFLAT-1, anticorps RFLAT1, anticorps 0610043C13Rik, anticorps 9430029L20Rik, anticorps Bteb3, anticorps FKLF-2, anticorps RGD1565099, anticorps Kruppel like factor 13, anticorps Kruppel-like factor 13, anticorps KLF13, anticorps klf13, anticorps Klf13

Sujet: RFLAT-1 is a novel protein belonging to the TFIIIA-like zinc finger protein superfamily and binds to the A site of the RANTES (Regulated upon Activation, Normal T cell Expressed and Secreted) chemokine. RANTES is involved in the generation of inflammatory infiltrate and HIV entry into immune cells.